Cvm Stock Forecast

View live Cel-Sci Corporation chart to track its stock's price action. Find market predictions, CVM financials and market news. Get CEL-SCI Corp (CVM:NYSE American) real-time stock quotes, news, price and financial information from CNBC. CVM Stock Overview · Revenue is forecast to grow % per year · Makes less than USD$1m in revenue ($0) · Shareholders have been diluted in the past year. Track Cel-Sci Corp. (CVM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable. For the fiscal quarter endingMar , the consensus EPS* forecast has remained the same over the past week at and remained the same over the past month at.

Stock price target for Cel-Sci Corp CVM are on downside and on upside. Stock price target for Cel-Sci Corp CVM are on downside and on. See Cel-Sci Corporation stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. Find the latest CEL-SCI Corporation (CVM) stock quote, history, news and other vital information to help you with your stock trading and investing. CVM CEL-SCI · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. K · Turnover Ratio. % · P/E (Static). Loss. Analyst Future Growth Forecasts. Earnings vs Savings Rate: CVM is forecast to remain unprofitable over the next 3 years. Earnings vs Market: CVM is forecast to. The CEL-SCI stock forecast for tomorrow is $ , which would represent a % gain compared to the current price. In the next week, the price of CVM is. Cel-Sci Corp. (CVM) has a Smart Score of 4 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. CVM CEL-SCI · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. M · Turnover Ratio. % · P/E (Static). Loss. CVM Price, Volume, Earnings, and Dividend Date ; Last Price$ ; Previous Close$ ; Change $ ; Open$ ; Volume, CEL-SCI Corp. analyst ratings, historical stock prices, earnings estimates & actuals. CVM updated stock price target summary. CVM / CEL-SCI Corporation (NYSEAM) - Forecast, Price Target, Estimates, Predictions ; Projected Stock Price. (%). Estimated share price by February

Find the latest CEL-SCI Corp (CVM) stock forecast, month price target, predictions and analyst recommendations. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. CVM will report earnings on. Over the past 43 months, CVM's average price target has gone down $ Over the past 39 weeks, CVM's average upside potential has been %. Date, Number. Performance Outlook · Short Term. 2W - 6W · Mid Term. 6W - 9M · Long Term. 9M+. news, forecast changes, insider trades & much more! Get Free CVM Updates Cel Sci's market cap is calculated by multiplying CVM's current stock price of $ Cel-Sci Corporation Common Stock (CVM) ; (%) ; Bid: $ x Ask: $ x ; Volume: , ; Mar 11, Is CEL-SCI Stock Undervalued? The current CEL-SCI [CVM] share price is $ The Score for CVM is 44, which is 12% below its historic median score. Find annual and quearterly earnings data for Cel-Sci Corporation Common Stock (CVM) including earnings per share, earnings forecasts at zflixxx.online Cel-Sci Stock Forecast, CVM stock price prediction. Price target in 14 days: USD. The best long-term & short-term Cel-Sci share price prognosis for.

This section shows how analysts expect the Cel-Sci Corporation CVM:US share price to perform in the future based on their earnings reports and estimates. It. For the upcoming trading day on Thursday, 14th we expect CEL-SCI Corporation to open at $, and during the day (based on 14 day Average True Range), to move. Forecast Oscillator Chande Momentum Oscillator Choppiness Index Commodity Channel Index Coppock Curve Correlation Coefficient Darvas Box Detrended Price. CVM's current price target is $ Learn why top analysts are making this stock forecast for CEL-SCI at MarketBeat. 5 analysts offering month price forecasts for Cel-sci Corp (CVM) have a share price target of $ This median of share price forecast represents a %.

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

javascript used for | learn how to do algebra

1 2 3 4 5

Copyright 2012-2024 Privice Policy Contacts